Prostate cancer is a leading cause of cancer-related death in males and is second only to
lung cancer. Although effective surgical and radiation treatments exist for clinically localized …

Abstract Characterization of the prostate cancer transcriptome and genome has identified
chromosomal rearrangements and copy number gains and losses, including ETS gene family …

Toward development of a precision medicine framework for metastatic, castration-resistant
prostate cancer (mCRPC), we established a multi-institutional clinical sequencing …

Recurrent chromosomal rearrangements have not been well characterized in common
carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal …

To identify CAP3 and CAP4, components of the CD95 (Fas/APO-1) death-inducing signaling
complex, we utilized nano-electrospray tandem mass spectrometry, a recently developed …

DNA microarray technology has led to an explosion of oncogenomic analyses, generating a
wealth of data and uncovering the complex gene expression patterns of cancer. …

Multiple, complex molecular events characterize cancer development and progression 1 , 2
. Deciphering the molecular networks that distinguish organ-confined disease from …

Prostate cancer is the most frequently diagnosed cancer in American men 1 , 2 . Screening
for prostate-specific antigen (PSA) has led to earlier detection of prostate cancer 3 , but …

Using the cytoplasmic domain of Fas in the yeast twohybrid system, we have identified a
novel interacting protein, FADD, which binds Fasand Fas-FD5, a mutant of Fas possessing …

Long noncoding RNAs (lncRNAs) are emerging as important regulators of tissue physiology
and disease processes including cancer. To delineate genome-wide lncRNA expression, …